colon cancer liver metastasis
Information
- Disease name
- colon cancer liver metastasis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03415126 | Completed | Phase 1 | A Study of ASN007 in Patients With Advanced Solid Tumors | January 19, 2018 | June 30, 2020 |
| NCT01522209 | Completed | N/A | Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging | December 2011 | January 2015 |
| NCT01526200 | Completed | Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases | October 2007 | December 2011 | |
| NCT01891552 | Completed | Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab | May 2013 | May 2015 | |
| NCT02090816 | Completed | Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy | September 2004 | December 2013 | |
| NCT02781935 | Completed | Diffusion-Weighted MRI for Liver Metastasis | November 2016 | September 27, 2023 | |
| NCT01730365 | Completed | Optical Detection of Malignancy During Percutaneous Interventions | October 2012 | December 2015 | |
| NCT05293041 | Recruiting | Phase 4 | Argipressin's Influence on Blood Loss During Hepatic Resection | March 27, 2022 | March 2025 |
| NCT04668872 | Recruiting | Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation | December 7, 2020 | December 7, 2024 | |
| NCT04682665 | Recruiting | Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases | September 16, 2021 | July 2025 | |
| NCT01464593 | Terminated | Phase 2 | Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) | September 2011 | June 2013 |
| NCT03370198 | Terminated | Phase 1 | Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer | October 11, 2017 | December 15, 2018 |
| NCT03310008 | Unknown status | Phase 1 | Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases | August 7, 2017 | May 2021 |
| NCT02631564 | Unknown status | Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis | June 2015 | December 2018 | |
| NCT02557490 | Unknown status | Phase 4 | Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases | January 2015 | December 2017 |
| NCT02363049 | Unknown status | Phase 3 | Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer | July 2014 | July 2018 |
| NCT03175016 | Unknown status | Phase 2/Phase 3 | Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer | June 20, 2017 | December 2019 |
| NCT01540435 | Withdrawn | Phase 2 | Perioperative Treatment of Resectable Liver Metastases | September 2012 | May 2013 |